Pivotal bioVenture Partners Fund I, L.P.

Overview

• HeadquartersE9¹

See how the biggest companies compare on our leaderboards

Corporate structure

Pivotal bioVenture Partners Fund I, L.P. sits at the top of its group. 7 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (6 companies). Each entity in the chart links to its source.

Stakes it holds

Pivotal bioVenture Partners Fund I, L.P. has told the SEC it owns more than 5% of 6 companies, latest first (Schedules 13D and 13G).

• Bolt Biotherapeutics, Inc.SCHEDULE 13D/A Feb 12, 2024 to Feb 26, 2026²
• Evommune, Inc.SCHEDULE 13G Feb 13, 2026³
• Oculis Holding AGSCHEDULE 13G/A Mar 15, 2023 to Nov 14, 2025⁴
• Inozyme Pharma, Inc.SCHEDULE 13D/A Feb 14, 2022 to Aug 27, 2025⁵
• RallybioSC 13D/A Feb 12, 2024⁶
• Akouos, Inc.SC 13G/A Feb 14, 2022 to Aug 25, 2022⁷